<?xml version="1.0" encoding="UTF-8"?>
<p id="Par69">The Herpesviridae family is one of the most prevalent human pathogens, and 90% of adults are infected by at least one of the eight herpesvirus subtypes [
 <xref ref-type="bibr" rid="CR60">60</xref>]. KSHV is the causative agent for multiple malignancies including Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL) and multicentric Castleman’s disease (MCD) [
 <xref ref-type="bibr" rid="CR61">61</xref>–
 <xref ref-type="bibr" rid="CR63">63</xref>]. Latency is common among all herpes viruses. Recently, Ye et al. discovered that reactivation of KSHV would be stalled when the newly transcribed viral RNAs fail to undergo post-transcriptional modification with m6A [
 <xref ref-type="bibr" rid="CR43">43</xref>]. Reactivation of the latent virus, resets the epigenetic processes, leading to the transactivation of viral genome [
 <xref ref-type="bibr" rid="CR64">64</xref>]. Therefore, a better understanding of the relationship between KSHV and m6A is a prerequisite for developing prevention and treatment strategies for KSHV-induced diseases.
</p>
